Lucius Labs
June 24, 2026
Theater 1
Type: Company Presentation
Focus Area:
Platform for Therapeutics
Lucius Labs is a modern leader in cell culture aiming to lower costs and increase productivity through rapid innovation of cell culture media, buffers and analytical services. The company specializes in creating high-performance, animal-component-free cell culture media for industries such as biopharmaceutical manufacturing, regenerative medicine, cell and gene therapy. Through the implementation of a rationally designed raw material program and the application of sophisticated data analytics, Lucius Labs offers custom, specialty media and classical media at significant price reductions. Their capabilities include rapid turnaround times often shipping in as little as two to four weeks. With a focus on scientific excellence and quality control, they provide scalable solutions ranging from pilot samples to large-scale production.
Company HQ City:
Emeryville
Company HQ State:
CA
Company HQ Country:
United States
Year Founded:
Lucius Labs (founded 2025), built on cell culture media capabilities established in 2023 within UPSIDE Group Inc. (founded 2016, originally named Memphis Meats)
Lead Product in Development:
Lucius Labs Cell Culture Media Portfolio
CEO
Uma Valeti
Development Phase of Lead Product
Other/Not Applicable
When you expect your next catalyst update?
September 2026
What is your next catalyst (value inflection) update?
Series D funding round
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}